SCHEMBL13601364

SCHEMBL13601364

CCOC(=O)OC(C)OC(=O)CN1CCC(C)CC1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.43
ALDH1A1 P00352 6/20 0.36
KDM4E B2RXH2 4/20 0.36
TSHR P16473 3/20 0.36
NPSR1 Q6W5P4 3/20 0.36
POLB P06746 2/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
HPGD P15428 1/20 0.36
GAA P10253 1/20 0.35
LMNA P02545 1/20 0.35
MEN1 O00255 1/20 0.35
RECQL P46063 1/20 0.35
KMT2A Q03164 1/20 0.35
CREBBP Q92793 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12842150 0.88 CYP1A2 (0.36) MAPTALDH1A1KDM4ETSHRSMN1; SMN2
SCHEMBL13601439 0.86 POLB (0.43) MAPTALDH1A1KDM4ETSHRPOLB
SCHEMBL12773998 0.85 CYP2C9 (0.37) MAPTALDH1A1KDM4ETSHRSMN1; SMN2
SCHEMBL13601395 0.83 TSHR (0.38) ALDH1A1KDM4ETSHRPOLBSMN1; SMN2
SCHEMBL12774086 0.82 CYP1A2 (0.37) MAPTALDH1A1KDM4ETSHRPOLB
SCHEMBL2663390 0.80 MAPT (0.48) MAPTALDH1A1KDM4ENPSR1POLB
SCHEMBL12774050 0.80 CYP1A2 (0.40) ALDH1A1TSHRPOLBSMN1; SMN2CYP1A2
SCHEMBL13601703 0.78 MAPT (0.48) MAPTALDH1A1KDM4EPOLBGAA
SCHEMBL28404629 0.73 ALDH1A1 (0.60) MAPTALDH1A1KDM4ETSHRNPSR1
SCHEMBL824216 0.71 ALDH1A1 (0.39) MAPTALDH1A1KDM4ETSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed